Expert: Approval of Aducanumab for Alzheimer Disease 'Is a Huge Accomplishment'

Video

Because there are no other available treatment options, Pamela Spicer said the approval of aducanumab gives much-needed hope to patients with Alzheimer disease and their families.

Despite the controversy surrounding the FDA approval of aducanumab for patients with Alzheimer disease, Pamela Spicer, senior analyst at Datamonitor with Informa Pharma Intelligence, said this is "a huge accomplishment."

Because there are no other available treatment options, Spicer said the approval of aducanumab gives much-needed hope to patients with Alzheimer disease and their families. She added that other investigational drugs for Alzheimer disease could have encouraging results in the future, but this approval offers a more immediate treatment option.

Related Videos
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.